EGFR IHC Test for Targeted Therapy | Lahalak Platform
This test determines tumor responsiveness to modern targeted therapies, especially in lung and colon cancers, ensuring better outcomes with fewer side effects.
Scientific name: Immunohistochemistry: Epidermal Growth Factor Receptor (EGFR)
Immunohistochemical (IHC) assay for epidermal growth factor receptor (EGFR) aims to detect overexpression of EGFR protein on the membrane of cancer cells. It is used as a preliminary or confirmatory indicator in some protocols prior to molecular testing (such as mutation screening) and is of particular importance in non-small cell lung cancer, colo...
Service type
Histopathology Laboratory Test
Duration
30-45 minutes
Fasting
Fasting is not required
Included Services
- Detailed analysis to detect EGFR receptor protein expression in tissue samples
- Consult a pathologist or oncologist to interpret the results.
- Personal support services from Lahalak
Medical Service Information
Conditions & Notices
- Fasting is not required, as the sample is tissue (biopsy or excision).
- The tissue sample must be immediately preserved in 10% formalin to preserve the antigens.
- The exact type of tumor (e.g., lung adenocarcinoma, colon cancer) and the purpose of the request (initial examination, determination of eligibility for targeted treatment) must be attached.
- The sample often requires review by a pathologist to select the appropriate tumor mass for analysis.
Medical services you might also like
